Lilly's Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays
Go back to Lilly's Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1152.93 +0.49 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.44 | 52 Week High | $88.16 | |||
| Open | $1150.00 | 52 Week Low | $67.88 | |||
| Day High | $1157.60 | P/E | 266.88 | |||
| Day Low | $1140.27 | EPS | $4.32 | |||
| Volume | 4,534,817 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.24 +0.05 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.19 | 52 Week High | $59.00 | |||
| Open | $43.50 | 52 Week Low | $32.80 | |||
| Day High | $43.54 | P/E | N/A | |||
| Day Low | $42.78 | EPS | $0.00 | |||
| Volume | 10,333,478 | |||||
